Your browser is no longer supported. Please, upgrade your browser.
Settings
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E59.29 EPS (ttm)2.11 Insider Own0.10% Shs Outstand1.35B Perf Week-1.13%
Market Cap167.42B Forward P/E21.90 EPS next Y5.72 Insider Trans-3.52% Shs Float1.35B Perf Month-0.46%
Income2.86B PEG6.53 EPS next Q1.42 Inst Own83.30% Short Float0.80% Perf Quarter4.62%
Sales27.93B P/S6.00 EPS this Y2.30% Inst Trans0.04% Short Ratio2.24 Perf Half Y13.63%
Book/sh37.70 P/B3.32 EPS next Y31.77% ROA3.10% Target Price134.31 Perf Year33.52%
Cash/sh10.95 P/C11.44 EPS next 5Y9.08% ROE5.70% 52W Range87.68 - 132.30 Perf YTD6.94%
Dividend2.32 P/FCF106.77 EPS past 5Y7.70% ROI6.70% 52W High-5.31% Beta0.81
Dividend %1.85% Quick Ratio1.70 Sales past 5Y7.40% Gross Margin64.30% 52W Low42.87% ATR1.85
Employees90000 Current Ratio2.10 Sales Q/Q0.80% Oper. Margin10.30% RSI (14)47.82 Volatility1.34% 1.41%
OptionableYes Debt/Eq0.60 EPS Q/Q-33.90% Profit Margin10.40% Rel Volume0.76 Prev Close124.19
ShortableYes LT Debt/Eq0.52 EarningsMay 27 BMO Payout106.00% Avg Volume4.79M Price125.27
Recom1.90 SMA20-2.34% SMA502.05% SMA20010.82% Volume3,687,588 Change0.87%
Apr-15-21Initiated Atlantic Equities Overweight $153
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $140
Dec-15-20Upgrade Goldman Sell → Neutral $100 → $119
Oct-08-20Upgrade Stifel Hold → Buy $125
Oct-08-20Upgrade Bernstein Mkt Perform → Outperform
Sep-11-20Initiated Wolfe Research Peer Perform $115
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-02-20Upgrade Guggenheim Neutral → Buy $135
Jun-05-19Upgrade Wells Fargo Market Perform → Outperform
Feb-04-19Reiterated Needham Strong Buy $120 → $117
Jan-03-19Initiated Deutsche Bank Buy $99
Jan-02-19Downgrade Citigroup Buy → Neutral
Dec-19-18Upgrade JP Morgan Neutral → Overweight
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $113
May-14-21 09:00AM  
07:15AM  
May-13-21 11:00AM  
11:00AM  
09:00AM  
May-12-21 12:47PM  
May-10-21 01:35PM  
09:27AM  
08:00AM  
May-06-21 09:32AM  
May-05-21 09:00AM  
May-03-21 03:51PM  
08:00AM  
08:00AM  
Apr-28-21 08:00AM  
Apr-27-21 10:00AM  
08:00AM  
Apr-26-21 08:00AM  
Apr-23-21 09:04AM  
Apr-22-21 04:31PM  
08:12AM  
Apr-21-21 12:41PM  
08:00AM  
08:00AM  
Apr-20-21 12:30PM  
12:30PM  
Apr-15-21 09:15AM  
06:27AM  
Apr-14-21 09:00AM  
07:42AM  
Apr-13-21 08:31AM  
06:50AM  
Apr-12-21 11:24PM  
07:00AM  
07:00AM  
Apr-07-21 09:33AM  
09:10AM  
09:00AM  
Apr-05-21 09:29AM  
Apr-01-21 10:00AM  
Mar-29-21 07:48AM  
07:08AM  
Mar-26-21 01:34PM  
08:38AM  
Mar-25-21 11:30AM  
Mar-24-21 11:30AM  
Mar-23-21 09:46AM  
08:49AM  
Mar-22-21 07:14PM  
02:10PM  
08:30AM  
08:30AM  
Mar-21-21 10:11AM  
Mar-19-21 08:38AM  
Mar-18-21 10:40AM  
Mar-17-21 09:00AM  
Mar-15-21 11:45AM  
10:09AM  
Mar-09-21 08:00AM  
07:00AM  
Mar-08-21 06:45AM  
06:45AM  
05:51AM  
Mar-07-21 03:53PM  
Mar-05-21 08:56AM  
Mar-04-21 11:33AM  
09:00AM  
09:00AM  
Mar-03-21 01:03PM  
10:00AM  
08:37AM  
Mar-02-21 11:34AM  
10:30AM  
Mar-01-21 11:01AM  
Feb-26-21 09:12AM  
Feb-25-21 12:39PM  
Feb-23-21 04:20PM  
02:00PM  
11:44AM  
09:40AM  
09:32AM  
07:21AM  
07:08AM  
07:07AM  
06:45AM  
06:45AM  
01:45AM  
Feb-19-21 08:16PM  
04:11AM  
Feb-18-21 01:34PM  
09:30AM  
09:00AM  
Feb-17-21 12:40PM  
11:00AM  
07:56AM  
06:57AM  
06:45AM  
06:45AM  
Feb-16-21 11:00AM  
08:30AM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Martha GeoffreyCEOApr 05Option Exercise52.5011,712614,92591,246Apr 07 04:28 PM
Martha GeoffreyCEOApr 05Sale118.8311,7121,391,73781,938Apr 07 04:28 PM
PARKHILL KAREN LEVP & Chief Financial OfficerMar 15Sale119.1263275,28486,556Mar 16 05:19 PM
TEN HOEDT ROBEVP & President EMEAMar 02Option Exercise34.887,168250,02050,965Mar 03 05:23 PM
TEN HOEDT ROBEVP & President EMEAMar 02Sale117.987,168845,68143,797Mar 03 05:23 PM
Surface Carol ASVP, Chief HR OfficerDec 28Sale114.9015,0001,723,50034,150Dec 30 04:42 PM
Lerman Bradley ESVP General Counsel & Corp SecDec 22Sale115.562,605301,03451,543Dec 23 04:35 PM
WHITE ROBERT JOHNEVP & Pres. Medical SurgicalDec 18Sale115.4610,9301,261,97844,922Dec 21 05:06 PM
PARKHILL KAREN LEVP & Chief Financial OfficerDec 15Sale114.3367076,60186,897Dec 16 05:34 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Option Exercise62.7620,7151,300,07374,863Nov 10 05:18 PM
Lerman Bradley ESVP General Counsel & Corp SecNov 09Sale113.1320,7152,343,48854,148Nov 10 05:18 PM
ISHRAK OMARExecutive ChairmanOct 09Sale108.4076382,709561,032Oct 14 06:38 PM
Lerman Bradley ESVP General Counsel & Corp SecOct 08Option Exercise62.7620,7141,300,01174,242Oct 09 05:12 PM
ANDERSON RICHARD HDirectorOct 08Buy108.524,607499,952101,673Oct 09 05:10 PM
Lerman Bradley ESVP General Counsel & Corp SecOct 08Sale110.0020,7142,278,54054,325Oct 09 05:12 PM
TEN HOEDT ROBEVP & President EMEASep 23Sale104.349,584999,99543,476Sep 25 05:42 PM
PARKHILL KAREN LEVP & Chief Financial OfficerSep 15Sale107.7870275,66287,366Sep 16 05:40 PM
TEN HOEDT ROBEVP & President EMEASep 09Sale105.059,5631,004,59353,060Sep 11 06:04 PM
Surface Carol ASVP, Chief HR OfficerMay 29Sale97.722,000195,44047,443Jun 02 05:39 PM